Cargando…
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only a small set of immune signaling domains have b...
Autores principales: | Castellanos-Rueda, Rocío, Di Roberto, Raphaël B., Bieberich, Florian, Schlatter, Fabrice S., Palianina, Darya, Nguyen, Oanh T. P., Kapetanovic, Edo, Läubli, Heinz, Hierlemann, Andreas, Khanna, Nina, Reddy, Sai T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630321/ https://www.ncbi.nlm.nih.gov/pubmed/36323661 http://dx.doi.org/10.1038/s41467-022-34141-8 |
Ejemplares similares
-
A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications
por: Palianina, Darya, et al.
Publicado: (2023) -
CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas
por: Baur, Katharina, et al.
Publicado: (2023) -
Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy
por: Nobili, Alberto, et al.
Publicado: (2022) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021) -
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)